Jack Rudd
Editorial Director, Analytical Cannabis
Jack has been working in science publishing since 2015 and has been the editorial lead of Analytical Cannabis since its launch in early 2017. He holds a 1st class Bachlor's in Biological Sciences from Essex University, where he received the distinguished Eliahou Dangoor scholarship for his work. He is also a member of ASTM Committee D37 on cannabis and attends a number of annual international cannabis science conferences. Prior to the launch of Analytical Cannabis, Jack worked in editorial for our parent publication, Technology Networks, where he focused on covering developments in cancer research, genomics, and informatics.
Latest content from Jack Rudd
Ultrasound-assisted Extraction of Cannabinoids: Double the Yield in Half the Time
With the rapid increase in demand for cannabis extracts, a recent study has highlighted a real opportunity for the optimization of alcohol-based extraction in a growing global market.
VIEW
User-friendly, Simple GC's Make Waves in the Cannabis Industry
We catch up with Andrew James from Ellutia to discuss how and why their 200 Series GC is proving popular for testing potency, flavour profiling, and residual solvents.
VIEW
UHPLC Enables Rapid Quantitation of Native Cannabinoids
A highly sensitive method for the quantitation of 11 major cannabinoids from cannabis samples has been outlined by researchers at the University of Mississippi.
VIEW
User-friendly, Simple GC's Make Waves in the Cannabis Industry
We catch up with Andrew James from Ellutia to discuss how and why their 200 Series GC is proving popular for testing potency, flavour profiling, and residual solvents.
VIEW
Chemotyping: Classifying cannabis strains by chemical composition
Grouping strains by chemotyping may prove useful in ascertaining how strains are related, and the kind of medical benefits you can expect to see with strains from a given chemotype class.
CBD vs THC – What are the Main Differences?
Here we look at some of the key differences, and similarities, between the most well-known cannabinoids, CBD and THC.
VIEW
Cannabis Medicine: Providing Patients with the Right Chemical Profile for Their Condition
Analyzing the complex chemistry of the cannabis plant may help scientists to develop specific cannabis-based drugs for specific conditions.
VIEW
Cannabis Testing in the Home of the Coffee Shop
The Netherlands has long been known for its relatively liberal approach to cannabis but testing is far from commonplace here.
VIEW
Cannabidiol: A potentially revolutionary treatment for PTSD
Evidence from neurobiological research points to cannabinoids as possible therapeutic agents of interest for PTSD, a condition that over 3.5 million people suffer with in the USA alone.
VIEW